Mucus Relief Dm Extended Release Caplets Tablet, Extended Release
NDC Package 17856-1162-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Mucus Relief Dm Extended Release Caplets (guaifenesin, dextromethorphan hbr) tablets is do not crush, chew, or break tablettake with a full glass of water this product can be administered without regards for timing of mealsadults and children 12 years of age and older: 1 or 2 tablet every 12 hours; not more than 4 tablets in 24 hourschildren under 12 years of age: do not use. This formulation utilizes a tablet, extended release delivery system. Marketed by Atlantic Biologicals Corp., this product is identified by NDC 17856-1162 and is authorized under FDA application ANDA209692.

Identification & Billing

NDC Package Code
17856-1162-1
Package Description
100 BLISTER PACK in 1 CARTON / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
Product Code
17856-1162
11-Digit Billing Format
17856116201
RxNorm Crosswalk
  • RxCUI: 1298324 - guaiFENesin 600 MG / dextromethorphan HBr 30 MG 12HR Extended Release Oral Tablet
  • RxCUI: 1298324 - 12 HR dextromethorphan hydrobromide 30 MG / guaifenesin 600 MG Extended Release Oral Tablet
  • RxCUI: 1298324 - dextromethorphan hydrobromide 30 MG / guaifenesin 600 MG 12 HR Extended Release Oral Tablet

Clinical Specifications

Proprietary Name
Mucus Relief Dm Extended Release Caplets
Non-Proprietary Name
Guaifenesin, Dextromethorphan Hbr
Substance Name
Dextromethorphan Hydrobromide; Guaifenesin
Dosage Form
Tablet, Extended Release - A solid dosage form containing a drug which allows at least a reduction in dosing frequency as compared to that drug presented in conventional dosage form.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Do not crush, chew, or break tablettake with a full glass of water this product can be administered without regards for timing of mealsadults and children 12 years of age and older: 1 or 2 tablet every 12 hours; not more than 4 tablets in 24 hourschildren under 12 years of age: do not use

Regulatory & Marketing

Labeler Name
Atlantic Biologicals Corp.
Product Type
Human Otc Drug
FDA Application #
ANDA209692
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
12-13-2018
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 17856-1162-1 identifies a specific commercial package of 100 blister pack in 1 carton / 1 tablet, extended release in 1 blister pack of Mucus Relief Dm Extended Release Caplets, a human over the counter drug labeled by Atlantic Biologicals Corp.. This tablet, extended release is formulated for oral use and contains dextromethorphan hydrobromide; guaifenesin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Atlantic Biologicals Corp. on December 13, 2018. The current certification is valid through December 31, 2026.

How is this Atlantic Biologicals Corp. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 17856116201. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
17856-1162-1
11-Digit CMS (5-4-2)
17856-1162-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.